文献速递肝病

肥大细胞促进西方饮食喂养小鼠的非酒精性脂肪性肝病表型及微泡性脂肪变性

Mast Cells Promote Nonalcoholic Fatty Liver Disease Phenotypes and Microvesicular Steatosis in Mice Fed a Western Diet.
PubMed 文献 · Hepatology · 2021-05-24

该研究探讨肥大细胞(MC)在非酒精性脂肪性肝病(NAFLD)进展中的作用。通过西方饮食喂养野生型及MC缺陷小鼠16周,并回输MC,发现MC促进胆管反应、炎症、纤维化及微泡性脂肪变性,其机制涉及miR-144-3p/ALDH1A3信号。抑制MC活化可能成为NAFLD/NASH治疗选择。

要点

  • MC缺陷减轻西方饮食诱导的肝损伤、胆管反应和微泡性脂肪变性。
  • MC回输加重WD诱导的胆管和肝脏损伤,并上调1区肝细胞微泡性脂肪变性。
  • MC通过miR-144-3p/ALDH1A3信号促进NAFLD向NASH进展。

核心结论

  • 肥大细胞促进西方饮食诱导的胆管和肝脏损伤,并可能通过miR-144-3p/ALDH1A3信号促进NAFLD向NASH进展中的微泡性脂肪变性。
  • 抑制肥大细胞活化可能是NAFLD/NASH的治疗选择。

研究设计与样本

  • 野生型(WT)和KitW-sh(MC缺陷)小鼠分别喂食对照饮食(CD)或西方饮食(WD)16周。
  • 部分WT和KitW-sh WD小鼠在处死前2周每周两次尾静脉注射MCs。
  • 人类样本来自正常、NAFLD或NASH患者。

主要发现

  • WT WD小鼠和人类NASH中MC存在增加,伴随胆管反应增加。
  • WT WD小鼠较WT CD小鼠显著增加脂肪变性、胆管反应/胆管细胞衰老、炎症、肝纤维化和血管生成,这些在KitW-sh WD小鼠中显著减少。
  • MC缺失显著减少1区肝细胞的微泡性脂肪变性。
  • MC注射促进WD诱导的胆管和肝脏损伤,并特异性上调1区肝细胞的微泡性脂肪变性。
  • ALDH1A3表达在WT WD小鼠和人类NASH中降低,但在KitW-sh WD小鼠中升高;miR-144-3p表达在WT WD小鼠和人类NASH中增加,但在KitW-sh WD小鼠中减少,且靶向ALDH1A3。

临床怎么用

  • 抑制肥大细胞活化可能作为NAFLD/NASH的治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Nonalcoholic fatty liver disease (NAFLD) is simple steatosis but can develop into nonalcoholic steatohepatitis (NASH), characterized by liver inflammation, fibrosis, and microvesicular steatosis. Mast cells (MCs) infiltrate the liver during cholestasis and promote ductular reaction (DR), biliary senescence, and liver fibrosis. We aimed to determine the effects of MC depletion during NAFLD/NASH. APPROACH AND RESULTS: Wild-type (WT) and KitW-sh (MC-deficient) mice were fed a control diet (CD) or a Western diet (WD) for 16 weeks; select WT and KitW-sh WD mice received tail vein injections of MCs 2 times per week for 2 weeks prior to sacrifice. Human samples were collected from normal, NAFLD, or NASH mice. Cholangiocytes from WT WD mice and human NASH have increased insulin-like growth factor 1 expression that promotes MC migration/activation. Enhanced MC presence was noted in WT WD mice and human NASH, along with increased DR. WT WD mice had significantly increased steatosis, DR/biliary senescence, inflammation, liver fibrosis, and angiogenesis compared to WT CD mice, which was significantly reduced in KitW-sh WD mice. Loss of MCs prominently reduced microvesicular steatosis in zone 1 hepatocytes. MC injection promoted WD-induced biliary and liver damage and specifically up-regulated microvesicular steatosis in zone 1 hepatocytes. Aldehyde dehydrogenase 1 family, member A3 (ALDH1A3) expression is reduced in WT WD mice and human NASH but increased in KitW-sh WD mice. MicroRNA 144-3 prime (miR-144-3p) expression was increased in WT WD mice and human NASH but reduced in KitW-sh WD mice and was found to target ALDH1A3. CONCLUSIONS: MCs promote WD-induced biliary and liver damage and may promote microvesicular steatosis development during NAFLD progression to NASH through miR-144-3p/ALDH1A3 signaling. Inhibition of MC activation may be a therapeutic option for NAFLD/NASH treatment.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Kennedy L, Meadows V, Sybenga A, et al. Mast Cells Promote Nonalcoholic Fatty Liver Disease Phenotypes and Microvesicular Steatosis in Mice Fed a Western Diet. Hepatology. 2021. PMID: 33434322. doi:10.1002/hep.31713

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。